Heron Therapeutics Announces Q4 Financial Results
By Amit Chowdhry ● Mar 24, 2023
Heron Therapeutics, Inc. (Nasdaq: HRTX) - a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care - announced its financial results for the three and twelve months ended December 31, 2022 and highlighted recent corporate updates.